Newsfeeds - Spark Newswire

2 minute read

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying

Today, 9:17 AM

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BTN

9 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:17 AM

On Monday, 160 companies hit new 52-week lows.

$APE

5 minute read

Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:17 AM

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also reported better-than-expected Q3 sales results.

AAN

5 minute read

Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

Today, 9:17 AM

Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.

AGEN

1 minute read

Earnings

DiaMedica Therapeutics: Q2 Earnings Insights

By Benzinga Insights

Today, 9:17 AM

DiaMedica Therapeutics (NASDAQ:DMAC) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement.

DMAC

1 minute read

DiaMedica Therapeutics Q2 EPS $(0.13) Beats $(0.18) Estimate

By Michael Horton

Today, 9:17 AM

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.18) by 27.78 percent. This is a 23.53 percent increase over losses of $(0.17) per share

DMAC

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

Today, 9:17 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

11 minute read

Earnings Scheduled For August 10, 2022

By Benzinga Insights

Today, 9:17 AM

Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.

AADI

1 minute read

Earnings

DiaMedica Therapeutics Earnings Preview

By Benzinga Insights

Today, 9:17 AM

DiaMedica Therapeutics (NASDAQ:DMAC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.

DMAC

2 minute read

3 Penny Stocks Insiders Are Buying: DiaMedica Therapeutics, Troika Media And More

By Lisa Levin

Today, 9:17 AM

U.S. stock futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

DMAC